Cargando…
TET2 Mutation May Be More Valuable in Predicting Thrombosis in ET Patients Compared to PV Patients: A Preliminary Report
Thrombosis is a common complication of myeloproliferative neoplasm (MPN), and it is a major cause of disability and death. With the development of next-generation gene-sequencing technology, the relationship between non-driver mutations and thrombotic risk factors has also attracted considerable att...
Autores principales: | Wang, Ziqing, Liu, Weiyi, Wang, Dehao, Yang, Erpeng, Li, Yujin, Li, Yumeng, Sun, Yan, Wang, Mingjing, Lv, Yan, Hu, Xiaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699342/ https://www.ncbi.nlm.nih.gov/pubmed/36431092 http://dx.doi.org/10.3390/jcm11226615 |
Ejemplares similares
-
Metabolic Biomarkers Affecting Cell Proliferation and Prognosis in Polycythemia Vera
por: Wang, Ziqing, et al.
Publicado: (2022) -
Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis
por: Yang, Erpeng, et al.
Publicado: (2021) -
Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia
por: Yang, Erpeng, et al.
Publicado: (2022) -
Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis
por: Wang, Ziqing, et al.
Publicado: (2021) -
Proteomic-Based Platelet Activation-Associated Protein SELP May Be a Novel Biomarker for Coagulation and Prognostic in Essential Thrombocythemia
por: Wang, Dehao, et al.
Publicado: (2023)